Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future.
Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford LM, Harms E, Ingelfinger JR, Koch VH, Langman CB, Leonard MB, Mannon RB, Sarwal M, Schneider JA, Skovby F, Sonies BC, Thoene JG, Trauner DA, Gahl WA; NIH Office of Rare Diseases. Kleta R, et al. Among authors: sarwal m. Pediatr Nephrol. 2005 Apr;20(4):452-4. doi: 10.1007/s00467-004-1777-5. Epub 2005 Jan 27. Pediatr Nephrol. 2005. PMID: 15747161 Review. No abstract available.
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.
Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschênes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P. Langman CB, et al. Among authors: sarwal m. Clin J Am Soc Nephrol. 2012 Jul;7(7):1112-20. doi: 10.2215/CJN.12321211. Epub 2012 May 3. Clin J Am Soc Nephrol. 2012. PMID: 22554716 Free PMC article. Clinical Trial.
Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate.
Langman CB, Greenbaum LA, Grimm P, Sarwal M, Niaudet P, Deschenes G, Cornelissen EA, Morin D, Cochat P, Elenberg E, Hanna C, Gaillard S, Bagger MJ, Rioux P. Langman CB, et al. Among authors: sarwal m. J Pediatr. 2014 Sep;165(3):528-33.e1. doi: 10.1016/j.jpeds.2014.05.013. Epub 2014 Jun 16. J Pediatr. 2014. PMID: 24948347 Free PMC article. Clinical Trial.
Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report.
Mannon RB, Morris RE, Abecassis M, Axelrod D, Bala S, Friedman GS, Heeger PS, Lentine KL, Loupy A, Murphy B, Nickerson P, Sarwal M, O'Doherty I, Spear N, Karpen SR. Mannon RB, et al. Among authors: sarwal m. Am J Transplant. 2020 Jun;20(6):1495-1502. doi: 10.1111/ajt.15833. Epub 2020 Mar 17. Am J Transplant. 2020. PMID: 32090461 Free article.
In praise of arrays.
Ying L, Sarwal M. Ying L, et al. Among authors: sarwal m. Pediatr Nephrol. 2009 Sep;24(9):1643-59; quiz 1655, 1659. doi: 10.1007/s00467-008-0808-z. Epub 2008 Jun 21. Pediatr Nephrol. 2009. PMID: 18568367 Free PMC article. Review.
Steroid elimination is coming of age.
Sarwal M. Sarwal M. Pediatr Nephrol. 2006 Jan;21(1):2-4. doi: 10.1007/s00467-005-2042-2. Epub 2005 Oct 20. Pediatr Nephrol. 2006. PMID: 16237567 Review.
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee. Haas M, et al. Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590. Am J Transplant. 2014. PMID: 24472190 Free article.
265 results